Pennant Group Inc
NASDAQ:PNTG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.31
36.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Pennant Group Inc
Cost of Revenue
Pennant Group Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
Cost of Revenue
-$435.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Encompass Health Corp
NYSE:EHC
|
Cost of Revenue
-$235.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Cost of Revenue
-$3.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Cost of Revenue
-$10.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Cost of Revenue
-$3.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-15%
|
|
Pennant Group Inc
Glance View
The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. The company is headquartered in Eagle, Idaho and currently employs 6,441 full-time employees. The company went IPO on 2019-09-19. The firm operates multiple lines of business, including home health, hospice and senior living across, Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The company provides home health and hospice services through approximately 88 agencies and senior living services at approximately 54 communities with approximately 4,127 units in its assisted living, independent living and memory care business. The firm operates through two segments: home health and hospice services, and senior living services. Home health and hospice services segment includes its home health, hospice and home care businesses. Senior living services segment includes its assisted living, independent living and memory care communities.
See Also
What is Pennant Group Inc's Cost of Revenue?
Cost of Revenue
-435.4m
USD
Based on the financial report for Dec 31, 2023, Pennant Group Inc's Cost of Revenue amounts to -435.4m USD.
What is Pennant Group Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-15%
Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Pennant Group Inc have been -14% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
